Roche launches academic-industry stem cell initiative

Roche Holding and the Innovative Medicines Initiative are establishing StemBANCC, a new academic-industry collaboration that aims to use human induced pluripotent stem cells as tools for drug discovery and research. The project will include 10 drugmakers and 23 academic institutions studying the use of human iPS cells for the identification of drug targets and biomarkers and the screening of drug benefits and toxicology. "The aim of StemBANCC is to generate and characterize 1,500 high-quality human induced pluripotent stem cell lines derived from 500 patients that can be used by researchers to study a range of diseases including diabetes and dementia," project coordinator Martin Graf said.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC